Lasofoxifene reduces breast cancer risk in postmenopausal osteoporotic women
Thursday, November 4, 2010 - 16:50
in Health & Medicine
Lasofoxifene statistically reduced the overall risk of breast cancer, as well as ER positive invasive breast cancer in postmenopausal women with low bone density, according to a study published online in The Journal of the National Cancer Institute.